SimuPharma — Phase 3: Strategic Alignment Retainer

Ongoing alignment and decision support as capital, partnerships, and complexity increase.

This phase maintains clarity across capital strategy, partnerships, and positioning as decisions begin to compound in real time.

__

Focus Areas

• continuous capital and partnership sequencing
• support during investor conversations
• refinement of funding strategy (equity + grants)
• real-time decision support as new variables emerge

__

What This Process Captures

– where new decisions introduce misalignment
– where capital conversations drift from positioning
– where partnerships create unintended complexity
– where execution begins to fragment under pressure

__

What You Receive

• Ongoing Strategic Alignment
• Real-Time Decision Support
• Capital + Partnership Sequencing Guidance
• Monthly System Review + Optimization
• Continuous Narrative Refinement

__

Outcome

Sustained clarity as complexity increases… ensuring decisions continue to compound rather than fragment.

__

Activation

This phase begins following Phase 2 or at the point alignment requires continuous support.